Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Dimerix announces positive data from phase II ACTION trials of DMX-200 in kidney disease

Oct. 28, 2020

J2H Biotech, Ahn-Gook Pharmaceutical describe new mirabegron prodrugs

Oct. 28, 2020

NOX5 is a therapeutic target in diabetic kidney disease

Oct. 9, 2020

Patient screening ongoing in phase IIa study of IP-2018

Oct. 6, 2020

CSL begins phase II study of CSL-346 in diabetic kidney disease

Oct. 2, 2020

Positive topline phase I data for ROSgard in patients with renal impairment

Sep. 30, 2020

Ultomiris approved in Japan for aHUS in adults and children

Sep. 29, 2020

Dimerix reports phase II data on DMX-200 in diabetic kidney disease

Sep. 14, 2020

Bayer initiates enrollment in phase II CONCORD study of runcaciguat

Sep. 10, 2020

First subject dosed in phase I study of ALLN-346

Sep. 9, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...